NanoBiotechnology Laboratory

Laboratory @ACBDresearch @MonashCCS @MonashUni led by Professor @cehagemeyer with a focus on antibody-based delivery of novel therapeutics and diagnostics

[NanoBiotechnology Laboratory @NanobiotechLab]

As historic MDMA decision nears, even J.P. Morgan eyes psychedelic investments https://t.co/h0mmrfgnTz

[NanoBiotechnology Laboratory @NanobiotechLab]

Longboard’s shares triple as epilepsy med halves seizure rates in early-stage trial https://t.co/2sAsEaD1Q1

[NanoBiotechnology Laboratory @NanobiotechLab]

Wishing everyone a wonderful festive season, fortunate to work and collaborate with such amazing people everyday, all the best for 2024.

[NanoBiotechnology Laboratory @NanobiotechLab]

Scalable human embryo model displays earliest stages of blood cell production https://t.co/KsyJdsKpTS

[NanoBiotechnology Laboratory @NanobiotechLab]

UPDATE: Roche muscles in on obesity market with $2.7B Carmot buyout, securing injectable and oral assets https://t.co/0RrZ281cjM

[NanoBiotechnology Laboratory @NanobiotechLab]

AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field https://t.co/lSZ6lhBtjk

[VBIC @VicBioImaging]

Just over a week until the VBIC Annual Network Meeting! Don't miss out on this opportunity to hear about the latest innovations in imaging research, as well as industry and commercialisation insights! Secure your spot now- https://t.co/QM2vzUivEv

[VBIC @VicBioImaging]

We are only 3 weeks away from the VBIC Annual Network Meeting!! Be sure to seize this opportunity to join fellow researchers and industry partners in Victoria's imaging community. Register now to secure your spot: https://t.co/lX5Ez5vnii

[NanoBiotechnology Laboratory @NanobiotechLab]

ESMO: As peers enter radiopharmaceuticals, Novartis says welcome to the party https://t.co/PfVDJENOHL

[NanoBiotechnology Laboratory @NanobiotechLab]

Roche's BTK inhibitor may have reached 'holy grail' of brain penetration in phase 2 MS trial https://t.co/Wat3a8PXLV

[NanoBiotechnology Laboratory @NanobiotechLab]

Incidental CAC missed in CT chest scans: study: https://t.co/GqwMYOPnkx

[NanoBiotechnology Laboratory @NanobiotechLab]

Novartis targets first-line use for radiotherapy Lutathera after trial win in neuroendocrine tumors https://t.co/Psnp4Gd5Xc

[NanoBiotechnology Laboratory @NanobiotechLab]

'Quantum therapeutic' triggers glioblastoma cells to self-destruct https://t.co/ZwSie02k6d

[NanoBiotechnology Laboratory @NanobiotechLab]

Blackstone's $250M bet beats Xarelto in bleeding trial, making case for Anthos' ex-Novartis asset https://t.co/xUcu7K1y4P

[NanoBiotechnology Laboratory @NanobiotechLab]

No more needles, an oral insulin medication could be on the horizon - Advanced Science News https://t.co/k5tBcV4Kmt

[NanoBiotechnology Laboratory @NanobiotechLab]

Eli Lilly hops aboard for Mariana Oncology's $175M series B, radiopharmaceuticals mission https://t.co/pkhtJ3tlU3

[NanoBiotechnology Laboratory @NanobiotechLab]

Australian R&D spending drops as percentage of GDP https://t.co/05sv7Gl8rw

[NanoBiotechnology Laboratory @NanobiotechLab]

RayzeBio plans IPO to push radiotherapy 'pipeline-in-a-product' through phase 3 https://t.co/HztiUjCsY2

[NanoBiotechnology Laboratory @NanobiotechLab]

https://t.co/Phs1l16FEM?

[NanoBiotechnology Laboratory @NanobiotechLab]

Johns Hopkins makes major investment in the power, promise of data science and artificial intelligence https://t.co/uZbQX2atSa via @HubJHU